News About: Pharm. Industry
Listed drug makers struggling to achieve targeted sales by March.
The leading pharmaceutical companies having a fiscal year ended at March 31 are struggling hard to achieve their annual sales targets until the end of March.
The distribution sources said that the drug companies of...
GSK symposium on Restless Legs Syndrome for Requip.
GSK Korea took a scientific symposium on Requip (ropinirole hydrochloride), the first FDA approved new drug for the treatment of the restless legs syndrome (RLS), by inviting Korean neuro and psychiatric physicians on...
GSK to hire 2 doctors specialized internal medicine.
GSK has hired 2 medical doctors, Dr. Choi Won and Dr. Kwon Nam-hee, who are specialized in the internal medicine and put them at the GSK medical science department.
Dr. Choi, a medical director (Sangmoo iesa), grad...
NHI reimbursement approved MSD's Syprine
MSD Korea has obtained the NHI reimbursement approval for Syprine (trientine hydrochloride) for the treatment of Wilson's disease, a rare disease, under the tradename of "MSD trientine" effective from Feb. 1. Syprine ...
Jeil to split stocks into 500 won par value.
In the 46th general shareholder's meeting on March 17 Jeil decided to amend partly the Article of Incorporation reflecting the current stock of 5000 won par value to split in 500 won.
The company reported the 2005 ...
LG and Hanmi at the top NHI drug bills of Korean drug makers.
According to "Top 100 drugs billed for NHI reimbursement in 2004 and 2005" disclosed by Rep. Ahn Myeong-ok, all foreign branded drugs occupied the top 10 except 2 domestic drugs such as LG's Zanidip and Hanmi's Amodi...
Zuellig to supply Bausch Rom products at 10% price increase.
Zuellig Pharma will supply Bausch Rom products. According to a reliable source on March 17, "Y" company who supplied exclusively Bausch Rom products through wholesalers only has made an exclusive distribution agreemen...
First Botox generic to be marketed by Meditox.
Meditox, a Korean bio venture company, has obtained the KFDA approval for the sale of "botulism injection", a generic of Botox, through their own technical development.
The development of an injectable botulism by ...
Handok to launch Tritace Protect.Handok launched a cardiovascular protective drug called "Tritace Protect" (ramipril 10mg) in to the Korean market, which was earlier proven of its therapeutic benefits through t...
|
Major drug maker's shareholder's meeting report in 2005.
Dong-A decided to pay 2% in stake and 12% in cash for shareholders.
In the shareholder meeting at the office auditorium on March 17 Dong-A management announced the dividends at 2% in stock and 12% in cash and appoi...
